Abstract
There has been a growing consensus that it is now important to protect children and young people by facilitating their participation in clinical trials rather than ‘protecting them from’ participation. Undoubtedly the inclusion of children and young people in clinical trials is ethically complex and has additional requirements to that of adult trials; however, establishing further medications and treatments that are safe and efficacious is essential.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
